IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 63.216
EU - Europa 35.202
AS - Asia 27.631
SA - Sud America 7.903
AF - Africa 634
Continente sconosciuto - Info sul continente non disponibili 156
OC - Oceania 58
Totale 134.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 60.187
SG - Singapore 11.570
RU - Federazione Russa 9.963
GB - Regno Unito 8.128
CN - Cina 6.953
BR - Brasile 6.461
IT - Italia 5.197
VN - Vietnam 3.837
DE - Germania 2.781
UA - Ucraina 2.596
CA - Canada 2.346
HK - Hong Kong 1.982
DK - Danimarca 1.583
SE - Svezia 1.018
IE - Irlanda 728
FR - Francia 699
FI - Finlandia 661
PL - Polonia 626
AR - Argentina 542
IN - India 534
MX - Messico 513
IL - Israele 391
BD - Bangladesh 370
TR - Turchia 355
NL - Olanda 346
ID - Indonesia 337
EC - Ecuador 297
ZA - Sudafrica 274
JP - Giappone 261
ES - Italia 249
IQ - Iraq 188
AT - Austria 176
PK - Pakistan 157
EU - Europa 149
CO - Colombia 143
LT - Lituania 106
PY - Paraguay 106
UZ - Uzbekistan 97
VE - Venezuela 96
AE - Emirati Arabi Uniti 93
MA - Marocco 93
CL - Cile 85
PE - Perù 72
SA - Arabia Saudita 62
KR - Corea 60
IR - Iran 57
UY - Uruguay 56
KE - Kenya 53
EG - Egitto 51
BE - Belgio 46
SK - Slovacchia (Repubblica Slovacca) 46
TN - Tunisia 41
CH - Svizzera 35
DZ - Algeria 33
JO - Giordania 33
AZ - Azerbaigian 31
BO - Bolivia 31
RO - Romania 31
AU - Australia 29
DO - Repubblica Dominicana 29
CZ - Repubblica Ceca 28
NP - Nepal 25
HN - Honduras 23
CR - Costa Rica 22
JM - Giamaica 20
KZ - Kazakistan 20
PH - Filippine 20
MY - Malesia 19
PT - Portogallo 19
AL - Albania 18
AM - Armenia 18
NZ - Nuova Zelanda 18
TW - Taiwan 17
CI - Costa d'Avorio 16
OM - Oman 15
TH - Thailandia 15
TT - Trinidad e Tobago 15
KG - Kirghizistan 14
KW - Kuwait 14
NI - Nicaragua 14
ET - Etiopia 13
GE - Georgia 13
LB - Libano 12
SN - Senegal 12
GT - Guatemala 11
PS - Palestinian Territory 11
BG - Bulgaria 10
GR - Grecia 10
GY - Guiana 10
PA - Panama 10
RS - Serbia 10
BB - Barbados 9
BH - Bahrain 9
BY - Bielorussia 9
HU - Ungheria 9
NG - Nigeria 9
LV - Lettonia 8
MC - Monaco 8
MD - Moldavia 8
GD - Grenada 7
Totale 134.638
Salva come PNG Salva come JPEG
Città #
Dallas 13.815
Singapore 6.114
Southend 5.518
Beijing 3.412
Ashburn 3.175
Woodbridge 2.868
Chandler 2.554
Ann Arbor 2.547
Houston 2.329
Fairfield 1.913
San Mateo 1.857
Los Angeles 1.799
Chicago 1.779
Hong Kong 1.750
Falls Church 1.553
Moscow 1.495
Dearborn 1.327
Seattle 1.321
Jacksonville 1.195
Wilmington 1.148
Cambridge 1.147
Ho Chi Minh City 1.051
Ottawa 943
The Dalles 818
Hefei 803
Salt Lake City 752
Boardman 730
Dublin 710
Stevenage 685
Portsmouth 682
Buffalo 681
New York 681
São Paulo 677
Dong Ket 641
Pisa 622
Warsaw 580
Hanoi 547
Lawrence 525
Santa Clara 446
Beauharnois 444
Brooklyn 425
Tampa 421
Munich 410
Montréal 406
Milan 386
Tel Aviv 351
Elk Grove Village 344
Rome 331
London 312
Montreal 251
Tokyo 233
Rio de Janeiro 221
San Diego 213
Denver 206
Stockholm 206
Florence 205
Frankfurt am Main 205
Poplar 202
Chennai 197
Johannesburg 191
Istanbul 189
Orem 185
Phoenix 182
Mexico City 177
Atlanta 173
Nuremberg 167
Sterling 163
Redwood City 160
Old Bridge 158
Lancaster 153
Boston 151
Belo Horizonte 132
Helsinki 132
Brasília 129
Miami 125
Toronto 125
Amsterdam 120
Haiphong 119
San Francisco 118
Guangzhou 116
Lappeenranta 115
Central District 114
Turku 113
Curitiba 108
Guayaquil 106
Manchester 101
Porto Alegre 99
Dulles 98
Council Bluffs 97
Ankara 96
Fremont 91
Tashkent 91
Campinas 90
Washington 89
Da Nang 87
Kansas City 86
Norwalk 85
Biên Hòa 84
Quito 84
Bologna 83
Totale 84.241
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.791
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.591
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.505
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.276
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 826
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 657
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 546
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 444
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 439
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 424
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 407
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 401
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 349
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 345
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 338
Cartella clinica automatizzata per il reparto di cardiologia 331
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 327
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 327
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 325
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 322
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 314
La neuropatia diabetica 311
An Open System for Managing Long Term ECG Recordings 310
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 308
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 307
Building medical knowledge from real world registries: The case of heart failure 306
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 303
A simple echocardiographic score to rule out cardiac amyloidosis 301
Central sleep apnea and cardiovascular disease state-of-the-art 299
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 298
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 291
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 290
Treating chemoreflex in heart failure: modulation or demolition? 289
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 289
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 287
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 286
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 284
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 283
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 279
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 279
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 278
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 278
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 276
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 276
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 276
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 275
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 274
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 273
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 271
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 271
Adrenergic activation in heart failure: blockade or rebalance? 270
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 267
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 266
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 265
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 265
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 265
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 263
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 261
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 260
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 258
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 258
Prediction of the chemoreflex gain by common clinical variables in heart failure 257
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 256
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 256
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 255
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 255
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 255
A simple echocardiographic score to rule out cardiac amyloidosis 252
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 252
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 252
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 250
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 250
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 250
Effects of smoking in patients treated with cardiac resynchronization therapy 250
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 250
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 250
[Central apneas and cardiovascular diseases] 248
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 248
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 248
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 247
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 247
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 243
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 243
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 243
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 242
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 242
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 242
Development of an Electronic Medical Record for Patient Care in Cardiology 242
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 242
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 240
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 240
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 239
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 239
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
Nuovi strumenti di management per la gestione integrata dei percorsi assistenziali dei pazienti cronici 237
Medical record System for Cardiology and Cardiac Surgery 236
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 235
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 235
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 233
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 232
Totale 34.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 721.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 721.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.529 0 0 0 0 0 1.601 1.075 605 923 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/202648.741 4.297 13.612 10.203 10.763 8.532 1.334 0 0 0 0 0 0
Totale 135.707